Overview

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether daily use of Duavee® is accepted and tolerated by peri- and post-menopausal women at moderate risk for development of breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas Medical Center
Collaborator:
Pfizer
Treatments:
Bazedoxifene
Estrogens
Estrogens, Conjugated (USP)